People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.
The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...
With turquoise waters, vibrant marine life, and a laid-back feel, Caye Caulker is perfect for your next beach vacation. At ...
Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...
A new EPA ban on TCE, a common industrial cleaning agent and contaminant, begins this year. UCSF’s Samuel Goldman, who led groundbreaking research to link TCE to Parkinson’s Disease, talks about the ...
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
Jan. 14, 2025 — There may be a link between hearing impairment and an increased risk of developing Parkinson's according to new research. This is one of the first studies to examine whether ...
The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...
Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...
In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...
University of Tasmania and Parkinson's Research Foundation bridge gap in Parkinson's knowledge with first of its kind resourceFree online course ...
"Parkinson's disease is the second most common neurodegenerative ... They found several potential risk genes (such as SNCA and LRRK2), many of which are known to cause inflammation in our brains ...